Wall Street RegretsThe regret calculator.

What if you'd held CPHI?

A $1,000 investment in China Pharma Holdings, Inc. (CPHI) at the month-end close of 2002-04 would be worth $0.12 at the close of 2026-08 — -100.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $7,157.

$1,000 since 2002$0.12Total return-100.0%Multiple0.00×CAGR-30.9%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$0.12Gain+$-1,000 (-100.0%)Multiple0.0×CAGR-30.9%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2002$0.122003$0.832004$0.722005$5.402006$1.202007$0.952008$0.712009$1.892010$0.562011$0.712012$3.222013$10.802014$6.172015$7.202016$13.502017$8.312018$12.002019$8.312020$9.002021$4.802022$4.502023$21.602024$1802025$4702026$893

    Every year, $1,000 from 2002

    YearValue of $1,000Year return
    2002$1,000
    2003$1,147+14.7%
    2004$153-86.7%
    2005$688+350.0%
    2006$868+26.1%
    2007$1,166+34.4%
    2008$436-62.6%
    2009$1,471+237.7%
    2010$1,158-21.3%
    2011$256-77.9%
    2012$76.44-70.1%
    2013$134+75.0%
    2014$115-14.3%
    2015$61.15-46.7%
    2016$99.37+62.5%
    2017$68.79-30.8%
    2018$99.37+44.4%
    2019$91.73-7.7%
    2020$172+87.5%
    2021$183+6.7%
    2022$38.22-79.2%
    2023$4.59-88.0%
    2024$1.76-61.7%
    2025$0.92-47.4%
    2026$0.83-10.7%

    Best and worst month-end to buy

    The best single month-end close to have bought CPHI was 2026-04 ($0.54): $1,000 then is $2,000 today. The worst was 2002-04 ($8,722): $1,000 then is $0.12.

    FAQ

    What would $1,000 in CPHI be worth today?

    A $1,000 investment in China Pharma Holdings, Inc. (CPHI) at the start of 2002 would be worth about $0.12 today, a total return of -100.0%. Dividends are reinvested in these figures.

    What were the best and worst years for CPHI?

    China Pharma Holdings, Inc. (CPHI)'s strongest calendar year since 2002 was 2005, a +350.0% return — $1,000 held through that year became about $4,500 by year-end. Its weakest year was 2023, at -88.0%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in CPHI have grown?

    Investing $100 at the end of every month since 2002-04 would have grown to about $2,636 on $29,300 invested.

    Did CPHI beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $7,157. CPHI trailed the S&P 500 by +100.0% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    China Pharma Holdings, Inc. (CPHI) historical total-return data from 2002-04 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.